Can-Fite BioPharma (NYSE:CANF) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock. Separately, HC Wainwright reduced their target price on shares of Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating on the stock in […]
More Stories
B. Riley Research Analysts Boost Earnings Estimates for LGTY
Logility Supply Chain Solutions, Inc. (NASDAQ:LGTY – Free Report) – Analysts at B. Riley boosted their FY2025 earnings per share...
Paul Grewal Sells 7,104 Shares of Coinbase Global, Inc. (NASDAQ:COIN) Stock
Coinbase Global, Inc. (NASDAQ:COIN) insider Paul Grewal sold 7,104 shares of the firm’s stock in a transaction on Monday, November...
Johnson Matthey (OTCMKTS:JMPLY) Sets New 52-Week Low – Time to Sell?
Johnson Matthey (OTCMKTS:JMPLY – Get Free Report) shares hit a new 52-week low during trading on Wednesday . The stock...
Keweenaw Land Association, Limited (OTCMKTS:KEWL) Short Interest Up 200.0% in November
Keweenaw Land Association, Limited (OTCMKTS:KEWL – Get Free Report) was the recipient of a large increase in short interest in...
Deutsche Telekom (ETR:DTE) Sets New 52-Week High – Should You Buy?
Deutsche Telekom AG (ETR:DTE – Get Free Report) shares hit a new 52-week high during trading on Wednesday . The...
Royce Micro-Cap Trust, Inc. (NYSE:RMT) Sees Significant Increase in Short Interest
Royce Micro-Cap Trust, Inc. (NYSE:RMT – Get Free Report) saw a significant growth in short interest in November. As of...